By rray, 12 July, 2024 Obtain PVR and UA cx UTI or incomplete emptying may be the reason for lack of sx improvement
By rray, 12 July, 2024 Evaluate pt 2wk after initial BTX injection Chance of UTI is highest 2wk post procedure
By rray, 12 July, 2024 If inadequate response to or intolerable side effects from pharmacotherapy or behavioral tx offer 1 of the following MR A
By rray, 12 July, 2024 Intradetrusor botulinum toxin BTX injection nbsp nbsp 100U intradetrusor BTX injection improves OAB sx in male and female pts w inadequate response to or who ve experienced intolerable side effects from antimuscarinics and or 3 agonists nbsp nbsp Low side
By rray, 12 July, 2024 Percutaneous tibial nerve stimulation PTNS nbsp nbsp darr of 2 voids day 1 2 nocturia episodes and 1 2 urinary incontinence episodes day vs baseline
By rray, 12 July, 2024 Sacral neuromodulation SNM nbsp nbsp Adverse events surgical revision for pain or infection device discomfort lead migration nbsp nbsp Assoc w high immediate and long term success rates 50 improvement in both BTX na ve pts and in those w an inadequate res
By rray, 12 July, 2024 If inadequate improvement w a single medication May offer combo tx w a medication from a different class e g antimuscarinic 3 agonist CR B
By rray, 12 July, 2024 If intolerable side effects or inadequate improvement May offer a different medication in the same class or a medication from a different class CP For pts on antimuscarinics switching to a 3 agonist may be more tolerable due to apparently lower rates of c
